Latest Market Positioning News

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.

Mach7 Technologies has been notified that the Veterans Health Administration will cease its NextGen PACS program, leading to a partial stop work order and cancellation of Phase 2 of the contract. Despite this, Mach7 remains focused on its broader commercial strategy.

Dateline Resources has bolstered its financial position with a $35 million institutional placement, setting the stage for expanded drilling and a strategic transition to U.S. reporting standards at its Colosseum Gold-REE Project in California.

Codeifai Limited has raised $1.1 million through a share placement to fund the commercialisation of a quantum-secured platform and broaden its AI capabilities into new industrial sectors.

EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.

Korvest Ltd has reported a robust half-year performance with revenues climbing 17.9% to $60.3 million and net profit after tax rising 33.2% to $5.444 million, driven by strong activity in its Industrial Products segment and strategic capital investments.

Codeifai Limited has responded to an ASX price query denying any undisclosed information behind recent unusual trading activity, while highlighting its nearing completion of the Antenna Transfer acquisition.

Connexion Mobility reported a slight revenue decline in Q2 FY26 but boosted net profit before tax by 18%, supported by expense cuts and steady subscription growth. The company’s strategic focus on expanding OEM and dealership relationships continues amid near-term sales team reductions.

Excite Technology Services has reported a record-breaking quarter with $9.2 million in customer receipts, marking a 125% increase year-over-year, alongside positive operating cash flow and strategic contract wins.

AMCIL Limited reported a 14.8% increase in half-year profit to $4.1 million, maintaining its interim dividend amid a portfolio return that lagged the ASX 200 benchmark.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Cogstate Ltd has reported a remarkable 105% surge in clinical trial sales contracts for the first half of 2026, surpassing revenue guidance and signalling a more diversified and resilient business model.